Imaging Agent May Provide Early Info About Benefits of Hormone Therapies for Breast Cancer
News
A new imaging agent that successfully measures changes in progesterone receptor (PR) levels may be used to determine if a breast cancer patient will respond to hormone therapies targeting the ... Read more